MOLECULAR NEUROIMAGING OF AIDS DEMENTIA: ANIMAL MODELS
$7,062P41FY2000RRNIH
Massachusetts Institute Of Technology, Cambridge MA
Investigators
Linked publications & trials
Paper 19728110Paper 19702261Paper 19203580Paper 18306400Paper 18025040Paper 17388596Paper 17323932Paper 16637644Paper 16505962Paper 16331423Paper 16222556Paper 16194295Paper 16041483Paper 16041480Paper 16004872Paper 15814917Paper 15798152Paper 15759297Paper 15610001Paper 15610000Paper 15452430Paper 15379538Paper 15341733Paper 15324754Paper 15253310Paper 15035634Paper 14872127Paper 14733572Paper 14695294Paper 14675538Paper 14664610Paper 14661955Paper 14648580Paper 14599177Paper 14568517Paper 14511600Paper 12939772Paper 12932461Paper 12815264Paper 12815260Paper 12769594Paper 12671978Paper 12660110Paper 12653563Paper 12652135Paper 12615147Paper 12565053Paper 12565042Paper 12490718Paper 12481032Paper 12426371Paper 12419681Paper 12358535Paper 12239329Paper 12207528Paper 12149447Paper 12137529Paper 11960452Paper 11916398Paper 11846590Paper 11841237Paper 11824761Paper 11781081Paper 11749563Paper 11567583Paper 11531354Paper 11504879Paper 11472128Paper 11472123Paper 11456650Paper 11425548Paper 11352724Paper 11258891Paper 11222853Paper 10968966Paper 10889021Paper 10856302Paper 10820006Paper 10783283Paper 10630997Paper 10617445
Abstract
The aim of this project is the characterization of in vivo and in vitro neuronal loss, neuronal dysfunction and brain metabolic abnormalities in an animal model of the AIDS dementia complex.
View original record on NIH RePORTER →